NCCN awards go to Green, Kumar, Black, and the COVID-19 Vaccination Advisory Committee

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

The National Comprehensive Cancer Network announced recognitions for the award-winning library of NCCN Guidelines for Patients and NCCN Patient Webinars.

June 21, 2024

Vol.50 No.25

Clinical Roundup

NCCN publishes patient resource for small bowel adenocarcinoma

The National Comprehensive Cancer Network has published NCCN Guidelines for Patients: Small Bowel Adenocarcinoma.

May 24, 2024

Vol.50 No.21

Clinical Roundup

NCCN and Polish oncology groups to adapt NCCN Guidelines for Poland

The National Comprehensive Cancer Network took part in two events in Warsaw focused on advancing cancer care and highlighting the Poland-US bilateral achievements in health care May 21-22.

May 24, 2024

Vol.50 No.21

In Brief

Daniel Geynisman named editor-in-chief of JNCCN

Daniel M. Geynisman was named the editor-in-chief of JNCCN—Journal of the National Comprehensive Cancer Network.

May 17, 2024

Vol.50 No.20

In Brief

Burke, Muir, Rauschecker, Smithy, Vega receive NCCN Foundation Young Investigator Awards

Zachary BurkeAlexander MuirAndreas RauscheckerJames SmithyJennifer N. VegaZachary Burke, Alexander Muir, Andreas Rauschecker, James Smithy, and Jennifer N. Vega received the 2024 National Comprehensive Cancer Network Foundation Young Investigator Awards.

April 19, 2024

Vol.50 No.16

NCCN awards go to Green, Kumar, Black, and the COVID-19 Vaccination Advisory Committee

YOU MAY BE INTERESTED IN

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

NCCN publishes patient resource for small bowel adenocarcinoma

NCCN and Polish oncology groups to adapt NCCN Guidelines for Poland

Daniel Geynisman named editor-in-chief of JNCCN

Burke, Muir, Rauschecker, Smithy, Vega receive NCCN Foundation Young Investigator Awards

Renew today!

Subscriber content

Login

NCCN awards go to Green, Kumar, Black, and the COVID-19 Vaccination Advisory Committee

YOU MAY BE INTERESTED IN

Platinum drugs are off the shortage list, but the underlying problem is unsolvedFDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

NCCN publishes patient resource for small bowel adenocarcinoma

NCCN and Polish oncology groups to adapt NCCN Guidelines for Poland

Daniel Geynisman named editor-in-chief of JNCCN

Burke, Muir, Rauschecker, Smithy, Vega receive NCCN Foundation Young Investigator Awards

Login

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”